In a concerning incident that has garnered significant attention, a mother has urged parents to heed dosage instructions for a widely used teething gel. Virginia resident Mia Thompson shared her alarming experience involving her 15-month-old daughter, Lily, who faced a serious health scare after being given a teething gel that was meant for children aged two and older.
Thompson recounted that on a fateful day, she applied a small amount of Orajel’s nighttime teething gel to Lily’s gums. Almost immediately, her daughter exhibited troubling symptoms. “Lily turned bright red, began kicking, and after just 10 to 15 seconds, she became unresponsive,” Thompson detailed on her social media. “Her eyes were wide open, but she was limp and not breathing. I was terrified.”
In a frantic attempt to revive her daughter, Thompson administered back blows before starting CPR while her partner called for emergency assistance. Fortunately, after what felt like an eternity, Lily began to cry and regained consciousness. Paramedics arrived shortly afterward and assessed that she was stable.
Though the outcome was positive, Thompson is determined to raise awareness about the potential dangers of the medication, particularly the misleading marketing that she believes contributed to her daughter’s situation. “The packaging states it’s for children over two, yet it features a baby on the front and is sold in baby aisles,” she lamented. “It’s incredibly misleading and should carry a more prominent warning or be removed altogether.”
Adding to the confusion, some retailers, like Target, promote the same product for infants starting at four months. While Thompson’s daughter was 15 months old, many parents, including herself, have occasionally administered medications outside recommended age limits, unaware of the serious risks involved.
Since sharing her story, Thompson has been contacted by numerous parents who have experienced similar incidents. “Many were shocked to learn about the dangers associated with this product,” she noted. “The FDA has also cautioned against the use of Benzocaine for infants, the active ingredient in Baby Orajel.”
Thompson expressed her reluctance to share such personal details online but felt compelled to inform others about the risks linked to using Baby Orajel Nighttime for children under two years old. “It’s critical for parents to understand what they might be exposing their children to,” she emphasized.
For parents navigating the world of teething and pain relief, it’s always advisable to consult reputable sources. This excellent resource on intrauterine insemination and family planning can offer valuable insights for those exploring their options. Furthermore, if you’re interested in family-building strategies, consider checking out the benefits of the at-home insemination kit, which can provide a unique approach to starting a family.
In summary, Mia Thompson’s experience serves as a crucial reminder for parents to always follow dosage instructions on medications and be wary of marketing that may mislead them. Awareness is key to ensuring the safety and well-being of our children.
Leave a Reply